By vgreene, 3 November, 2021 vancomycin 30 mg kg day max 2 g dose IV divided q12h or linezolid 600 mg IV PO q12h or clindamycin 300 450 mg PO qid or 600 900 mg IV IM q6 8h if susceptible or
By vgreene, 3 November, 2021 cefazolin 1 2 g IV q8h or ceftriaxone 1 2 g IV q24h or nafcillin 1 2 g IV q4 6h if MSSA suspected or vancomycin 30 mg kg day max 2 g dose IV divided q12h if MRSA suspected or linezolid 600 mg IV PO q12h if MRSA suspected
By vgreene, 3 November, 2021 cephalexin 500 mg PO qid or dicloxacillin 500 mg PO qid or clindamycin 300 450 mg PO qid or 600 mg IV IM q6 8h if local Staph aureus resistance
